Workflow
Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization
MDAISpectral AI(MDAI) Newsfilter·2025-03-24 11:30

Core Viewpoint - Spectral AI, Inc. has successfully completed a debt financing agreement of up to 15million,whichwillsupportthecommercializationofitsAI−drivenDeepView®Systemforpredictingburnhealingpotential[1][2][3]FinancingDetails−Thefinancingagreementhasatermofthreeyears,withaninitialdrawdownof15 million, which will support the commercialization of its AI-driven DeepView® System for predicting burn healing potential [1][2][3] Financing Details - The financing agreement has a term of three years, with an initial drawdown of 8.5 million and a potential additional 6.5millioncontingentuponFDAclearanceoftheDeepViewSystem[1][2]−Thefinancingincludesaninterest−onlypaymentperiodofatleast15months,extendableto24monthsuponmeetingspecificmilestones[2]−Theagreementalsofeatureswarrantcoverageof8.56.5 million contingent upon FDA clearance of the DeepView System [1][2] - The financing includes an interest-only payment period of at least 15 months, extendable to 24 months upon meeting specific milestones [2] - The agreement also features warrant coverage of 8.5% of the total funding commitment, with an exercise price of 1.80 per share [2] Company Strategy and Goals - The funds will enable Spectral AI to accelerate its product commercialization efforts, particularly the upcoming U.S. launch of the DeepView System [1][3] - The company aims to transform healthcare providers' ability to predict burn wound healing potential, ultimately improving patient outcomes [3][4] Product Overview - The DeepView System utilizes multi-spectral imaging and AI algorithms to provide an objective assessment of a burn wound's healing potential prior to treatment [4] - The technology is designed to exceed current standards of care, offering faster and more accurate treatment insights, thereby reducing healthcare costs [4]